Autoimmune encephalitis in Molde, Western Norway 2004-2017 von Eikeland, E.T., Willumsen, J.S., Midgard, R., Vedeler, C.A.

Volltext

1945P Stroma-derived bIgH3 (βigH3/TGFBI) is the local mediator of pathological TGFβ activity in pancreatic cancer and a target to treat in patients with high fibrotic activity von Karsdal, M.A., Willumsen, N., Bager, C., Nissen, N.I., Teo Hansen Selnø, A., Mohamed, K.E., Pedersen, R.S., Chen, I., Johansen, J.S., Henriksen, K.

Volltext

156P The association between fibrotic endotypes, determined by pre-treatment serum levels of collagen metabolites, and survival outcomes in patients with pancreatic cancer von Pedersen, R.S., Thorlacius-Ussing, J., Nissen, N.I., Johansen, A., Chen, I., Jensen, C., Hansen, C., Karsdal, M., Johansen, J.S., Willumsen, N.

Volltext

126P Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab von Nissen, N.I., Kehlet, S., Boisen, M.K., Liljefors, M., Jensen, C., Johansen, A.Z., Johansen, J.S., Erler, J., Karsdal, M.A., Mortensen, J., Høye, A., Willumsen, N.

Volltext

Clinical utility of serum type III collagen in patients with pancreatic carcinoma von Chen, I., Willumsen, N., Dehlendorff, C., Johansen, A., Vittrup, B.V., Krüger, M., Pfeiffer, P., Bjerregaard, J.K., Bojesen, S.E., Nielsen, S.E., Holländer, N.H., Yilmaz, M.K., Rasmussen, L.S., Karsdal, M., Johansen, J.S.

Volltext

436 The Prospective Epidemiologic Risk Factor (PERF I) Study: A novel prognostic serum biomarker reflecting type I collagen degradation is associated with tumor burden von Kehlet, S.N, Bager, C.L, Willumsen, N, Dragsb, K, Neergaard, J.S, Hansen, H.B, Bay-Jensen, A.C, Oersnes-Leeming, D.J, Christiansen, C, Karsdal, M.A

Volltext